Loading clinical trials...

COMPLETEDPhase 2NCT01662037

Bosentan Therapy in Children With Functional Single Ventricle

Bosentan is a kind of dual endothelin receptor antagonist.The purpose of this study is to investigate if Bosentan therapy can modify the outcome of children with functional single ventricle.

Lead sponsor: Shanghai Jiao Tong University School of Medicine•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects

NCT06442592 · Congenital Heart Defects, Neurodevelopmental Disorder

Active Not Recruiting

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

NCT01196182 · Congenital Heart Defects

COMPLETEDPhase 3

A Extension Study of Udenafil in Adolescents

NCT03013751 · Functional Single Ventricle Heart Disease

Not Yet Recruiting

Bioabsorbable Occluder for Outlet VSD: Safety and Aortic Valve Effects

NCT07040579 · Congenital Heart Defects, VSD

COMPLETEDPhase 2

Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?

NCT02232399 · Congenital Heart Defects

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 10, 2012Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment34

Start dateJan 2010

Last updatedAug 10, 2012

Condition

Congenital Heart Defects Functional Single Ventricle

Locations shown

Cardiac intensive care unit, Department of cardiothoracic vascular surgery, Shanghai Children's Medical Center, Medical college of Shanghai Jiaotong University

Shanghai, Shanghai Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 10, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions